about
It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer DiseasePharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular DiseaseThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationElevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brainAberrant insulin signaling in Alzheimer's disease: current knowledgeSex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusionEffects of UVB-induced oxidative stress on protein expression and specific protein oxidation in normal human epithelial keratinocytes: a proteomic approachProteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation.Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues.Involvement of Stat3 in mouse brain development and sexual dimorphism: a proteomics approach.Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysisProteomic analysis for the study of amniotic fluid protein compositionHeme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activityActivation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits.Antioxidants in cervical cancer: chemopreventive and chemotherapeutic effects of polyphenols.Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancer.Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.Mass spectrometry and redox proteomics: applications in disease.Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of ageThe Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.Increased Mammalian Target of Rapamycin Signaling Contributes to the Accumulation of Protein Oxidative Damage in a Mouse Model of Down's Syndrome.Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways.Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics.Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesisAutoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients.Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B.
P50
Q26765816-D88521AE-A54C-4976-A90F-BAE4451439C9Q26782422-4A73C11A-F021-457F-87C6-8995A7666C2EQ26823454-88C3F79D-D393-4E2C-B248-22DA080579E2Q27003253-42629210-DDD6-4FA2-B996-808DB29E7B3AQ27024222-E4542124-1B6D-4013-BF23-2F3BBB90CF8BQ28383413-CD324318-1076-4FC0-9681-2A61B5B8AC7FQ28391350-B27BACF9-854C-4D2C-A852-B7C0E339EABAQ33415671-C21E5024-088F-4DCC-A2FF-498555C9F1A1Q33775384-0B69ACAE-53D0-4B6B-8FA6-05A4853F42D7Q34094516-16A2D1D9-9B5F-45B8-AFE7-A14CA7F56CB3Q34217919-92C3730A-8432-4282-9040-163EE077B0DBQ34288258-CD17F493-04D1-435F-8594-11F7701A7205Q34590312-6BF82F7D-AFBB-4A95-9AFB-CFA887388EEDQ34769676-4F62DF0D-956F-400E-9D38-15F136554BC0Q35755815-6D9A3E6B-1B8D-45A9-8C9C-7EEDBBE8CE5CQ36041047-F4BE4C3D-99F9-450A-B786-68C8C289D35EQ36074438-F0664B5A-7BAC-40DE-935D-3A42031EC804Q36367840-64E45F2E-21EA-49B2-BBDE-CC2DE1DC1F37Q36390685-1AA29F2F-8185-4EF7-A154-CC2F80677959Q37125290-5CD3A793-E974-4B57-B52A-16B42CC4212CQ37141585-88CDC706-E8D5-4B8C-83C2-054D09972091Q37613081-BFEBCE64-AB0B-4781-ABCC-F36A7560CEEBQ37662773-24BC2E1F-C56C-42FF-B0FF-DBBD66FD7542Q37948475-E7B66DCC-AAF7-4092-AADB-CD2C7585DA6EQ37948489-8D09659E-3B7A-4510-80AE-21139EEBEC49Q38151763-318A9266-6303-4BFF-B006-EC19A9F7B607Q38162657-4278EB2E-BBCF-44E5-8CF8-FD33D957DD23Q38220377-16F2B86D-35AB-442E-ABAB-C50DF3F5B3D9Q38253060-42918EEF-1730-4C1D-AA9B-20DF52861F58Q38793564-1C694181-D468-48DB-8785-BE17E39DB2A9Q38809489-A1576C50-CD6A-4417-88CC-B3A915F04031Q38809514-8591F33B-E4FA-41E8-82CC-AEE460773F00Q38815881-E2A28B09-54E6-4BF0-A8DA-8E86E05564BCQ38816807-3EDB4189-4EC6-4E42-A781-E58CDF65E292Q38899588-537D3D3F-0CC3-420F-821D-DC00C022BCD8Q39549042-332A03D8-7C48-4C93-8244-31283365A9CBQ39756716-34B94699-C004-432F-90A4-AE3D18FA84E4Q40199344-D95B0040-F6FC-4776-8DAD-71D88E093243Q40203973-92B29709-93BD-49CA-8B4E-1EE1E8E0027AQ41786653-9BE4F6F3-C34B-454D-B190-9550F440EFAD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabio Di Domenico
@ast
Fabio Di Domenico
@en
Fabio Di Domenico
@es
Fabio Di Domenico
@nl
Fabio Di Domenico
@sl
type
label
Fabio Di Domenico
@ast
Fabio Di Domenico
@en
Fabio Di Domenico
@es
Fabio Di Domenico
@nl
Fabio Di Domenico
@sl
prefLabel
Fabio Di Domenico
@ast
Fabio Di Domenico
@en
Fabio Di Domenico
@es
Fabio Di Domenico
@nl
Fabio Di Domenico
@sl
P1053
J-4767-2018
P106
P1153
26323071000
P21
P2798
P31
P3829
P496
0000-0002-2013-209X